Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2022-11-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
北京市竞天公诚律师事务所关于重药控股股份有限公司2022年第五次临时股东大会的律师见证法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and voting results of a specific shareholders' meeting (the 2022 fifth extraordinary general meeting) of a company. It details the legality and compliance of the meeting's call, attendance, voting procedures, and results. It does not contain financial statements or performance data, nor is it a report or announcement of financial results. It is not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's conduct. Given the nature of the document as a legal opinion on a shareholders' meeting, it fits best under Regulatory Filings (RNS), which is the fallback category for legal and compliance documents that do not fit other categories.
2022-11-11 Chinese
2022年第五次临时股东大会会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions from the 2022 fifth extraordinary general meeting of shareholders of the company. It details the meeting date, voting methods, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and resolutions. It does not contain financial statements or detailed financial analysis but focuses on the official voting results and meeting procedures. The document length is short (1814 characters) and it is clearly a formal announcement of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-11-11 Chinese
关于持股5%以上股东减持计划的预披露公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a planned shareholding reduction by a shareholder holding more than 5% of the company's shares. It details the shareholder's identity, the number and percentage of shares to be reduced, the timing and method of the reduction, and compliance with relevant stock exchange rules. There are no financial statements, earnings data, or management discussion of financial results. The document is a notification of a major shareholding change, specifically a planned reduction by a significant shareholder. This fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on this announcement, not a full report or regulatory filing. Therefore, the correct classification is MRQ with high confidence.
2022-11-09 Chinese
关于持股5%以上股东减持股份达1%暨减持计划实施完毕的公告
Major Shareholding Notification Classification · 95% confidence The document is an official announcement regarding the reduction of shareholding by a shareholder holding more than 5% of the company's shares. It details the shareholder's share reduction plan, the actual shares reduced, the methods of reduction, and the impact on shareholding percentages. It includes tables with shareholding before and after the reduction and confirms compliance with relevant securities laws and regulations. There is no financial performance data, earnings information, or management discussion. The document is a notification of a significant shareholding change by a major shareholder, fitting the definition of a Major Shareholding Notification (MRQ). The document length is 3333 characters, which is typical for such announcements. Therefore, the correct classification is MRQ with high confidence.
2022-11-09 Chinese
关于召开2022年第五次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2022 fifth extraordinary general meeting of shareholders for Chongqing Pharmaceutical Holdings Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items, registration details, and proxy voting instructions. There is no financial data, earnings information, or management discussion of financial results. The document is not a report itself but a notice about the meeting and voting process. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures rather than the solicitation materials or the actual voting results, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it contains substantive details about the meeting and voting process, not just a brief announcement. Therefore, the classification is PSI with high confidence.
2022-11-08 Chinese
关于5%以上股东减持计划实施进展暨减持数量过半的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, dates, prices, and compliance with relevant regulations. It does not contain financial statements or detailed financial analysis but focuses on shareholding changes and regulatory compliance related to share reduction. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2022-11-04 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.